Archive by Author
Protein Lets Brain Repair Damage casued by Multiple Sclerosis
A protein that helps build the brain in infants and children may aid efforts to restore damage from multiple sclerosis (MS) and other neurodegenerative diseases, researchers at Washington University School of Medicine in St. Louis have found.
In a mouse model of MS, researchers found that the protein, CXCR4, is essential for repairing myelin, a protective [...]
Liberation Treatment gains traction
More than a year after the news of Dr. Zamboni’s discovery, more and more ms patients are getting the procedure known as ‘liberation treatment’ done. Here are some updates and testimonials:
http://www.cmaj.ca/earlyreleases/3may10-cdn-trials-to-examine-liberation-procedure-for-ms.dtl
http://www.king5.com/health/Poland-hospital-doing-controversial-treatment-for-multiple-sclerosis-90976229.html
Surprisingly simple cure for Multiple Sclerosis possible
An Italian doctor from the Université de Ferrara who set on a quest to cure his wife may have found a cure to MS.
Italian Dr. Paolo Zamboni has put forward the idea that many types of MS are actually caused by a blockage of the pathways that remove excess iron from the brain – [...]
Tovaxin
Opexa Therapeutics, Inc. announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS). This analysis evaluated patients with an annualized relapse rate of one or greater at study entry (ARR≥1). More than 83% of the Tovaxin-treated group (n=85) remained relapse free at [...]
Full StoryGalanin (a protein) offers new hope for a multiple sclerosis cure
Scientists in Bristol claim results from a research project into multiple sclerosis (MS) could lead to treatment to reduce the severity of the disease.
The team carried out tests on mice and found those with higher levels of galanin, a protein within brain nerve cells, were resistant to MS.
Researchers at Bristol University say it may [...]
Inflammation and paralysis reversed with common blood pressure medication
Conventional blood pressure medication can treat inflammation in an animal model mimicking multiple sclerosis (MS). This discovery was made by Dr. Michael Platten, head consultant at the department of Neurooncology at Heidelberg University Hospital and head of the Helmholtz Experimental Neuroimmunology Junior Research Group on at the German Cancer Research Center and his team in [...]
Full StoryMS in mice reversed with one shot
An experimental treatment has yeilded incredible results in mice with a disease similar to multiple sclerosis.
The new treatment, named GIFT15 puts MS into remission by suppressing the immune response. This means it might also be effective against other autoimmune disorders like Crohn’s disease, lupus and arthritis, the researchers said, and could theoretically also control immune [...]
Stem cell therapy helps patients with multiple sclerosis
Finally an article from a reputable source about advances being made using adult stem cells to fight multiple sclerosis. Here is the article from Scientific American:
Using a method known as autologous non-myeloablative haemopoietic stem cell transplantation, Burt and his colleagues essentially eliminated misbehaving immune cells and replaced them with healthy ones (made from stem cells) [...]
Two New Genes Discovered
Researchers in New Zealand and Australia have discovered two new gene locations that are responsible for triggering MS.
Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease.
Their findings will be published today in the [...]
Diabetes Drug May Help Treat MS
U.S. medical researchers say they’ve found a drug used to treat diabetes shows protective effects in the brains of some multiple sclerosis patients.
Researchers at the University of Illinois-Chicago College of Medicine say they conducted a small, double-blind clinical trial involving patients with relapsing remitting multiple sclerosis. The patients were assigned to take pioglitazone — a [...]
